1. 147: Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer. (January 2015) Authors: Wong, S.-L.; Morley, T.; Meng, K.; Mahmood, W.; Forster, M.; Mendes, R. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (January 2017) Authors: Kordbacheh, T.; Chan, C.; Bossons, A.; Franks, K.; McDonald, F.; Forster, M.; Mendes, R.; Quezada, S.; Dovedi, S.; Ralph, C.; Popat, S.; Harrington, K.; Melcher, A.; Popple, A.; Illidge, T.; Faivre-Finn, C. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 168: PD-RAD: A translational study investigating PD-L1 expression after radiotherapy for non-small cell lung cancer (NSCLC). (January 2017) Authors: Kordbacheh, T.; Chan, C.; Faivre-Finn, C.; Franks, K.; McDonald, F.; Forster, M.; Mendes, R.; Quezada, S.; Dovedi, S.; Ralph, C.; Popat, S.; Harrington, K.; Melcher, A.; Popple, A.; Illidge, T. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 23 Characteristics of lung cancer patients diagnosed following emergency admission. (January 2016) Authors: Ruparel, M.; Ejaz, A.; Chauhan, N.; Ridge, M.; Chung, D.; Succony, L.; Banka, R.; Thakrar, R.; Kumar, N.; Sage, E.; Forster, M.; Janes, S.; Newsom-Davis, T.; Ahmad, T.; Navani, N. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3112 Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer. (September 2015) Authors: Forster, M.; Hackshaw, A.; Pas, T. De; Cobo, M.; Garrido, P.; Summers, Y.; Dingemans, A.M.; Flynn, M.; Von Wangenheim, U.; Temple, G.; Loembé, A.B.; Lee, S.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors. (September 2015) Authors: Forster, M.; Sessa, C.; Von Moos, R.; Brown, N.; Metaxas, Y.; Griguolo, G.; Lardelli, P.; Coronado, C.; Juan, L.; Fernandez-Teruel, C.; Soto-Matos, A.; Stathis, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England. (January 2017) Authors: Yip, K.; Conibear, J.; Woolf, D.; Tarver, K.; Willis, B.; Hall, S.; Sun, F.; Kuhan, H.; Lambourne, B.; Piskilidis, P.; Kussaibati, R.; Martin, L.; Satar, N. Abdul; Gray, C.M.N.; Khan, A.; Doherty, G.; Prewett, S.; Smith, M.; Dancey, G.; Patterson, D.M. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adverse childhood experiences and alcohol related negative consequence among college student drinkers. (January 2023) Authors: Forster, M.; Rogers, C.J.; Tinoco, S.; Benjamin, S.; Lust, K.; Grigsby, T.J. Journal: Addictive behaviors Issue: Volume 136(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours. (November 2018) Authors: Arkenau, H.-T.; Italiano, A.; Mak, G.; Toulmonde, M.; Baird, R.D.; Garcia-Corbacho, J.; Plummer, R.; Flynn, M.; Forster, M.; Wilson, R.H.; Tosi, D.; Adenis, A.; Donaldson, K.; Posner, J.; Kawabata, I.; Arimura, A.; Deva, S.; Spicer, J. Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chiral segregation driven by a dynamical response of the adsorption footprint to the local adsorption environment: bitartrate on Cu(110). Issue 11 (2nd March 2017) Authors: Darling, G. R.; Forster, M.; Lin, C.; Liu, N.; Raval, R.; Hodgson, A. Journal: Physical chemistry chemical physics Issue: Volume 19:Issue 11(2017) Page Start: 7617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗